Circulating Endothelial Cells in Refractory Pulmonary Hypertension in Children: Markers of Treatment Efficacy and Clinical Worsening

BACKGROUND: Pulmonary vasodilators in general and prostacyclin analogues in particular have improved the outcome of patients with pulmonary arterial hypertension (PAH). Endothelial dysfunction is a key feature of PAH and we previously described that circulating endothelial cell (CEC) level could be...

Descripción completa

Detalles Bibliográficos
Autores principales: Levy, Marilyne, Bonnet, Damien, Mauge, Laetitia, Celermajer, David S., Gaussem, Pascale, Smadja, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677895/
https://www.ncbi.nlm.nih.gov/pubmed/23762293
http://dx.doi.org/10.1371/journal.pone.0065114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677895/
https://www.ncbi.nlm.nih.gov/pubmed/23762293
http://dx.doi.org/10.1371/journal.pone.0065114

Ejemplares similares